Registration and Breakfast

Opening Remarks

Interventional Management of Stroke III update

Post Interventional Management of Stroke III practice

Acute Basilar Artery Occlusion-Lessons learned from Basilar Artery International Cooperation Study

Statistical Interpretation of the IMS III Trial

Discussion

Abstract 1

Abstract 2

Break

Professor Led Rounds: Pharma Corpororate Supporter

Comparing Mechanical Thrombectomy Devices: Solitaire, Merci, and Penumbra

Optimizing Implementation: Peri-procedural times not device determines outcome

Stents for acute ischemic stroke: a viable option?

Discussion

Abstract 3

Abstract 4

Lunch symposium (Sit down lunch)

Featured lecture: Can endovascular procedures compete with improving best medical management

Abstract 4

Abstract 5

Break

Professor Led Rounds: Pharma Corpororate Supporter

Does supplemental imaging help in acute ischemic stroke patient selection

Solitaire, a new device to improve the treatment of acute ischemic stroke: Insights from the SWIFT trial

Endovascular treatment after 6 hours: Hope or hype

Penumbra revisited: insights from translational basic research?

Discussion

Abstract 7

Abstract 8

Introduction into the platelet PAR-1 receptor inhibitors

New generation of antiplatelet medications and neuroendovascular procedures

Flow Models: Solitaire, Pipeline, Penumbra, Aneurysm coiling, Onyx embolization

Dinner Reception

Walker Art Museum

Cocktail hour, appetizers and museum tour

Dinner Reception

Carotid artery stent placement vs. carotid endarterectomy: case closed

Carotid artery stent placement vs. carotid endarterectomy: An international perspective

Re-analysis of CREST and ICST using weighted outcomes?

Carotid artery stent placement vs. carotid endarterectomy: Is cost-effectiveness important

Discussion

Abstract 9

Abstract 10

Break

Professor Led Rounds: Pharma Corpororate Supporter

Case based presentation: When and how to treat

Abstract 11

Abstract 12

Lunch symposium (Sit down lunch)

Featured lecture: Establishing equipoise in clinical trials involving endovascular procedures: rising above beliefs, notions, and ignorance

Abstract 13

Abstract 14

Break

Professor Led Rounds: Pharma Corpororate Supporter

Flow diversion is the future of intracranial aneurysm treatment

Durability of endovascular treatment: Does it matter anymore

Is surgical treatment of aneurysm obsolete or awaiting a comeback?

AVM associated intracranial aneurysms: treatment challenges

Discussion

Abstract 15

Abstract 16

Break

Professor Led Rounds: Pharma Corpororate Supporter

Interpreting the SAMMPRIS results

Are there patients who can benefit from endovascular treatment today?

What’s next after self expanding stents: new stent or primary angioplasty?

Performing intracranial angioplasty/stent placement: IRBs, informed consent, and quality assurance committees in the post SAMMPRIS era

Flow Models: Solitaire, Pipeline, Penumbra, Aneurysm coiling, Onyx embolization

Dinner Reception

Hilton Hotel

Cocktail hour and appetizers

Dinner Reception

Breakfast

Endovascular treatment and the AHA guidelines for cerebral venous thrombosis

Spinal venous circulation and involvement in fistulas and malformations: to preserve or to sacrifice

Stent placement in the dural venous sinuses for intracranial hypertension

Dural venous sinus revascularization for multiple sclerosis- Shall we wait for the evidence

Discussion

Abstract 17

Abstract 18

Break

The bleeding thrombosis paradox with antiplatelet agents: Insight from the REACH registry

Point of care testing in the angiographic suite

Discussion

Abstract 19

Abstract 20

Lunch (Sit down lunch)

Joint commission perspective on comprehensive stroke centers and endovascular procedures

Are number of procedures in US adequate for training and maintaining competency

Starting an endovascular practice in an academic setting

Starting an endovascular practice in private practice settings

Discussion

Flow Models: Solitaire, Pipeline, Penumbra, Aneurysm coiling, Onyx embolization